ArticleFrontiers in cellular and infection microbiology2026
Exosome-enriched extracellular vesicles are associated with Getah virus RNA and transmission-related readouts
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exosome-enriched extracellular vesicles are associated with Getah virus RNA and transmission-related readoutsFrontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Getah virus (GETV) is a mosquito-borne alphavirus of veterinary importance with potential zoonotic relevance. Extracellular vesicles (EVs) can facilitate intercellular transfer of viral components, but their involvement in GETV infection remains unclear. Methods: Exosome-enriched EV fractions were isolated from supernatants of GETV-infected HeLa, BHK21, and PK15 cells by ultracentrifugation followed by CD9 immunoaffinity enrichment (HeLa) or iodixanol density gradient fractionation (BHK21/PK15). EV-associated viral RNA and infection-related readouts were analyzed using RT-PCR, RT-qPCR, immunoblotting, immunofluorescence, transmission electron microscopy, and uptake assays. Results: Exosome-enriched EV fractions were enriched for canonical EV markers and were associated with genome-spanning GETV RNA. Exposure of recipient cells to these fractions resulted in EV uptake, increased intracellular GETV RNA levels, and viral protein expression. RNase protection assays showed that the RNA signal was resistant to RNase treatment unless membranes were disrupted, consistent with membrane-protected RNA. In donor HeLa cells, GW4869 treatment reduced EV recovery and EV-associated GETV RNA levels and decreased transmission-related readouts in recipient cells, while having limited effects on cell-free virus replication in donor cells. Discussion: Together, these findings support the existence of an EV-associated route that may contribute to GETV transmission-related processes
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.